Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...
Mochi Health offers two subscription-based weight loss programs: Mochi Health and Wellness Plus. While anyone can access the ...
Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and ...
A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...
This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...
The Cochrane Database of Systematic Reviews has compared the long-term results from semaglutide (Ozempic, Wegovy) and ...
Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.
GlobalData on MSN
Massive sales for weight loss drugs spur Eli Lilly’s Q3
Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...
The South Korean government said Monday it plans to tighten regulations on the misuse of medications such as Wegovy and ...
A “KIND and loving” mum-of-three tragically died after being injected with a black market fat jab by a beautician at a salon.
Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results